Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
13F holders, Q3 2022
Institutional positions in Biofrontera Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q2 2022
- Shares held
- 853.8K
- −756.6K (−47.0%) vs. Q2 2022
- Total value
- $900.0K
- −$2.11M (−70.1%) vs. Q2 2022
- New holders
- 5
- 4 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BFRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $2.61M |
| Q1 2026 | 12 | $1.94M |
| Q4 2025 | 14 | $1.33M |
| Q3 2025 | 13 | $2.39M |
| Q2 2025 | 10 | $1.45M |
| Q1 2025 | 12 | $1.18M |
| Q4 2024 | 14 | $1.97M |
| Q3 2024 | 9 | $1.43M |
| Q2 2024 | 12 | $1.05M |
| Q1 2024 | 11 | $1.67M |
| Q4 2023 | 8 | $26.2K |
| Q3 2023 | 8 | $142.2K |
| Q2 2023 | 13 | $412.7K |
| Q1 2023 | 16 | $517.9K |
| Q4 2022 | 14 | $729.4K |
| Q3 2022 | 16 | $900.0K |
| Q2 2022 | 15 | $3.01M |
| Q1 2022 | 12 | $2.66M |
| Q4 2021 | 15 | $5.29M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Biofrontera Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bard Associates Inc | 253,275 | $266.0K | 0.12% | −6,000−2.3% | Reduced |
| Vanguard Group Inc | 212,590 | $223.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 118,588 | $125.0K | 0.00% | +7,827+7.1% | Added |
| Schonfeld Strategic Advisors LLC | 91,300 | $96.0K | 0.00% | −600−0.7% | Reduced |
| Geode Capital Management, LLC | 74,012 | $77.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,900 | $24.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 20,728 | $22.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 15,000 | $19.0K | 0.00% | −10,000−40.0% | Reduced |
| Jane Street Group, LLC | 15,064 | $16.0K | 0.00% | +4,874+47.8% | Added |
| Renaissance Technologies LLC | 13,934 | $15.0K | 0.00% | +13,934 | New |
| Tower Research Capital LLC (TRC) | 8,669 | $9.00K | 0.00% | +8,669 | New |
| UBS Group AG | 4,740 | $5.00K | 0.00% | +4,740 | New |
| Advisor Group Holdings, Inc. | 2,750 | $3.00K | 0.00% | +375+15.8% | Added |
| Wells Fargo & Company | 103 | $0 | 0.00% | +45+77.6% | Added |
| Morgan Stanley | 14 | $0 | 0.00% | +14 | New |
| Royal Bank of Canada | 106 | $0 | 0.00% | +106 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −763,637−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −270−100.0% | Sold out |